{
    "2021-11-26": [
        [
            {
                "time": "",
                "original_text": "万泰生物：将根据发展需求及实际情况适时推出股权激励计划",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "股权激励",
                        "发展需求"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：鼻喷新冠疫苗已进入国际多中心的Ⅲ期临床试验阶段",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "鼻喷新冠疫苗",
                        "Ⅲ期临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}